EV Biologics, Inc.

EV Biologics, Inc.

YECO
EV Biologics, Inc.US flagOther OTC
0.00
USD
- -
- -
2,890.00Market Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
TTM
Revenue per Share
17.89
18.73
28.89
17.88
3.95
35.34
Basic EPS, GAAP
4.23
4.5
5.42
-22.3
-3.08
-65.32
Free Cash Flow per Basic Share
-1.16
4.7
2.61
-9.79
-0.16
-18.75
Dividend per Share
- -
- -
- -
- -
- -
- -
Book Value per Share
1.14
5.35
13.26
-13.4
-16.35
-21.06
Tangible Book Value per Share
10.26
14.83
26.09
3.82
0.69
2.26
Basic Weighted Avg Shares
2
2
2
2
2
2
Sales/Revenue/Turnover
42
44
46
43
10
62
Operating Margin (%)
33.23
34.23
27.81
7.47
-41.34
-4.1
Depreciation Expense
1
1
2
2
1
2
Net Income, GAAP
10
11
9
-53
-7
-115
Effective Tax Rate (%)
22.44
23.36
25.03
- -
- -
24.16
Profit Margin (%)
23.66
24.05
18.77
-124.73
-78.15
-184.87
Working Capital
1
13
-4
-14
-21
-19
LT Debt
1
- -
- -
- -
- -
- -
Total Equity
27
38
47
11
4
6
Return on Invested Capital (%)
- -
26.88
17.74
- -
- -
15.52
Return on Capital (%)
- -
65.02
34.43
- -
- -
30.6
Return on Common Equity (%)
- -
138.94
51.18
- -
- -
44.38

Capital Structure

FRC

in mil. unless spec.
Jun'16
Sep'17
Dec'17
ST Debt
10
10
9
LT Borrowings
- -
- -
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
2
2
2
Market Capitalization
4
6
2

Working Capital

FRC

in mil. unless spec.
Jun'16
Sep'17
Dec'17
Total Current Assets
11
10
9
Cash, Cash Equivalents & STI
3
3
2
Accounts Receivable, Net
6
5
5
Inventories
- -
1
- -
Total Current Liabilities
25
28
28
Payables & Accruals
13
13
14
ST Debt
10
10
9
Deferred Revenue
3
4
5

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
-66.99%
Free Cash Flow
- -
- -
-98.38%
Net Income, GAAP
- -
- -
-86.03%
Sales/Revenue/Turnover
- -
- -
-77.71%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2016
13
13
11
5
43
2017
3
43
- -
- -
10
2018
39
- -
- -
- -
- -

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2016
1.51
0.88
1.06
- -
-22.3
2017
-1.18
-111.49
- -
- -
-3.08
2018
-0.93
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2016
- -
- -
- -
- -
- -
2017
- -
- -
- -
- -
- -
2018
- -
- -
- -
- -
- -

Company Description

APIChatGPT
CEO
Daniel S. McKinney
Full Time Employees
284
Sector
Healthcare
Industry
Biotechnology
Address
1621 Central Avenue Cheyenne WY United States of America 82001
IPO Date
Jun 29, 2015
Business
Yulong Eco-Materials Limited (YECO) is an investment holding company primarily engaged in the manufacture and sale of eco-friendly building products in China. The company operates through three main segments: the Yulong Bricks segment, which produces and sells fly-ash bricks; the Yulong Concrete and Yulong Transport segment, which produces and sells ready-mixed concrete; and the Yulong Renewable segment, which handles hauling and processing of construction waste along with production and sales of recycled aggregates and recycled bricks. Incorporated in 2011 and headquartered at the Eastern End of Xiwuzhuang Village, Jiaodian Town, Xinhua Area, Pingdingshan, Henan Province, China, Yulong employs 259 people and focuses on vertically integrated operations in the construction materials industry, primarily serving regional markets in and around Pingdingshan and Henan Province. Recent developments include the operational launch of a state-of-the-art recycling plant and brick plant with two production lines since April 2015, establishment of a research and development center for new eco-friendly products, acquisition of an exclusive hauling license through 2032 for construction waste in Pingdingshan's built-up area, expansion of its truck fleet from 50 to 120 units, and commencement of waste hauling and recycling operations in August 2015 for a high-speed railway project in Shangqiu, Henan Province, generating over 1.3 million metric tons of waste. The company reported trailing twelve-month revenue of $5.67 million and net income of $40.68 million as of the latest available data.

Company News

APIChatGPT
  • United States Lime & Minerals (NASDAQ:USLM) and Yulong Eco-Materials (OTCMKTS:YECO) Critical Contrast

  • Smith-Midland (NASDAQ:SMID) and Yulong Eco-Materials (OTCMKTS:YECO) Critical Review

  • EV Biologics Updates on Funding and Sales

  • EV Biologics Completes Production of Cutting-Edge MSC Exosome-Based Therapeutic

  • EV Biologics Appoints Senior Investment Banker as Corporate Finance Director

  • EV Biologics Hires Senior Chief Financial Officer

  • EV Biologics Updates on NFT Minting

  • EV Biologics Updates on NFT Warrant Dividend Distribution

  • EV Biologics Briefs Shareholders on Market Cap Peer Comparison

  • EV Biologics NFT Dividend Information

  • EV Biologics NFT Dividend Warrant Date

  • EV Biologics Starts Custom Cell Isolation with Lonza Cell Bio Services

  • EV Biologics Unveils NFT Dividend Warrant

  • EV Biologics Signs LOI with Lonza Cell & Gene Therapy

  • EV Biologics Confirms Funding to Commence Cell Line Generation & Advance Exosome Research